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ABSTRACT
Calcium electroporation (CaEP) describes the use of electric pulses 
(electroporation) to transiently permeabilize cells to allow supraphysiological 
doses of calcium to enter the cytosol. Calcium electroporation has successfully been 
investigated for treatment of cutaneous metastases in a clinical study. This preclinical 
study explores the possible use of calcium electroporation for treatment of sarcoma.
A normal murine muscle cell line (C2C12), and a human rhabdomyosarcoma cell 
line (RD) were used in the undifferentiated and differentiated state. Electroporation 
was performed using 8 pulses of 100 µs at 600–1000 V/cm; with calcium (0, 0.5, 
1, and 5 mM). Viability was examined by MTS assay, intracellular calcium levels 
were measured, and expression of plasma membrane calcium ATPase (PMCA) was 
investigated using western blotting. Calcium/sodium exchanger (NCX1), ryanodine 
receptor (RyR1) expression and cytoskeleton structure (zyxin/actin) were assessed 
by immunofluorescence. CaEP efficiency on RD tumors was tested in vivo in immuno-
deficient mice. 
CaEP was significantly more efficient in RD than in normal cells. Intracellular Ca2+ 
levels after CaEP increased significantly in RD, whereas a lower increase was seen 
in normal cells. CaEP caused decreased expression of PMCA and NCX1 in malignant 
cells and RyR1 in both cell lines whereas normal cells exhibited increased expression 
of NCX1 after CaEP. Calcium electroporation also affected cytoskeleton structure in 
malignant cells.
This study showed that calcium electroporation is tolerated significantly better 
in normal muscle cells than sarcoma cells and as an inexpensive and simple cancer 
treatment this could potentially be used in connection with sarcoma surgery for local 
treatment.
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INTRODUCTION
Rhabdomyosarcoma is the malignant tumor derived 
from myoblasts and mainly affects children and young 
adults. Due to the most frequent localization in muscle 
tissue, tumor resection often impacts functional outcomes 
[1, 2]. The function of muscle fibers is based on electrical 
stimulation and calcium signaling [3]. Calcium plays a 
crucial role in physiological processes such as cell cycle, 
proliferation, differentiation, apoptosis, and necrosis [4]. 
Normally, the concentration of calcium ions [Ca2+] in the 
cytoplasm is maintained in the range of 10–100 nM, while 
the extracellular Ca2+ concentration is 1–2 mM. Calcium 
metabolism is tightly regulated by numerous pumps and 
ion channels located in the cell membrane, including 
PMCA (Plasma membrane calcium ATPase), SERCA 
(Ca2+ pump of sarcoplasmic reticulum), NCX (Na+/Ca2+ 
exchanger), and RyR (ryanodine receptor) [5]. Drastic 
increases in intracellular calcium ion concentration may 
affect cytoskeleton structure and mitochondria function, 
which cause cell swelling and in consequence lead to cell 
death [6].
Electroporation (EP), i.e. short high-voltage electric 
pulses causing transient cell membrane permeabilization, 
can be used to change intracellular calcium ions 
concentration (calcium electroporation, CaEP [7]) and may 
affect normal and malignant cells differently. Previous 
studies have shown that malignant cells are more sensitive 
to calcium electroporation than normal cells in vitro 
and in vivo [8–10]. It has also been shown that calcium 
electroporation is associated with acute and severe ATP 
depletion across tested cell lines (H69 – human small-
cell lung cancer, SW780 - human bladder cancer, HT29, 
Human colon cancer, MDA-MB231 – human breast 
cancer, U937 – human leukemia, DC-3F - transformed 
Chinese hamster lung fibroblast cell line as well as 
HDF-n - primary normal human dermal fibroblasts) [7, 
11–13]. Interestingly, pretreatment ATP levels did not 
vary significantly between cell lines indicating that it may 
not be the pretreatment ATP level but rather sensitivity to 
depletion which determines impact on viability. In support 
of this, in a study on 3D spheroids, we observed ATP 
depletion in both a normal and malignant cell spheroids. 
However, whereas viability in normal cell spheroids was 
unperturbed after calcium electroporation, malignant cell 
spheroids were severely affected [12].
We hypothesize that different composition of the 
cell membrane and cytoskeleton structure, as well as 
dissimilar ion channel expression might reveal various 
reactions between normal and malignant cells after 
calcium electroporation. Indeed, the differential response 
to calcium electroporation could also be associated with 
cell differentiation.
In this study, we investigated the effect of calcium 
electroporation on normal and malignant muscle cells, 
undifferentiated and differentiated as well as under 
different experimental conditions (suspended and 
attached cells). We also investigated if a difference 
in treatment response between normal and malignant 
cells was correlated to differential expression of ion 
channel proteins and changes of cell structures. Finally, 
we studied the influence of calcium electroporation on 
rhabdomyosarcoma tumors in vivo. 
RESULTS
We have previously shown that calcium 
electroporation (CaEP) significantly decreased sarcoma 
cells viability and led to apoptotic cell death. Interestingly, 
we also demonstrated higher survival ratio in normal 
muscle cells after treatment compared with sarcoma 
cells [8]. In this study, we have confirmed these results 
by showing higher toxicity of calcium electroporation 
on sarcoma cells (RD) compared to normal muscle 
cells (C2C12). Additionally, and not previously shown, 
differentiation process increased cell survival ratio for 
both cell lines. Furthermore, we have compared the 
expression of plasma membrane calcium ATPase (PMCA), 
sodium-calcium exchanger (NCX), and ryanodine receptor 
(RyR) as well as structural changes in the two cell lines 
before and after treatment, which is all described below.
Influence of CaEP in vitro
We investigated the effect of calcium electroporation 
in vitro in normal muscle cells (C2C12) and sarcoma cells 
(RD), respectively undifferentiated and differentiated, 
as well as in suspension and attached (Figure 1). Three 
electroporation parameters (600 V/cm, 800 V/cm and 1000 
V/cm) were tested in the presence of 0.5 mM and 5 mM 
calcium. As expected, calcium electroporation induces 
cell death, and the highest electric field combined with 
the highest calcium concentration tested caused the lowest 
cell survival for both cell lines (p < 0.01). The viability of 
RD sarcoma cells decreased after calcium electroporation 
in all the investigated cases. Interestingly, the normal 
C2C12 cells were significantly less affected than the RD 
cells (p < 0.05), except in two treatment combinations 
(undifferentiated, attached cells treated with 5 mM 
calcium electroporation using 600–800 V/cm; Figure 1C). 
The difference in effect of calcium electroporation 
between undifferentiated and differentiated cells has not 
previously been compared. In this study we showed that 
differentiated cells (both cell lines) had 5–10% higher 
survival ratio than undifferentiated cells; however, 
not significantly different (Figure 1B and 1D). After 
differentiation, the C2C12 cells (C2C12-D) still indicated 
better tolerance to calcium electroporation than RD cells 
after differentiation (RD-D) (p < 0.01). 
When comparing the effect of calcium electroporation 
on attached and suspended cells, it seemed that attached 
cells tolerated the treatment better than suspended 
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cells (around 20% higher survival of normal cells and 
10% higher survival of malignant cells); however not 
significantly different. Interestingly, attached C2C12 and 
C2C12-D have 25% higher viability after 0.5 mM calcium 
electroporation (all EP parameters) compared to untreated 
cells (p < 0.001; Figure 1C and 1D). This is not seen with 
malignant cells, why the largest difference between normal 
and malignant cells is seen for attached cells treated with 
0.5 mM calcium electroporation (p < 0.001). 
Intracellular calcium level after calcium 
electroporation
Since calcium electroporation was less effective 
in normal than malignant muscle cells, we investigated 
intracellular calcium level in both cell lines, undifferentiated 
(C2C12, RD) and differentiated (C2C12-D, RD-D), before 
and after calcium electroporation. 
Figure 2A shows the intracellular calcium content 
in untreated normal and malignant cell lines, both 
differentiated and undifferentiated. Calcium content was 
approximately twice as high in untreated C2C12 as in 
RD cells (p < 0.0001) and in C2C12-D as in RD-D (p < 
0.001). The differentiation process also increased calcium 
content in both cell lines, especially in C2C12-D where 
the calcium level was 43% higher than in C2C12 (p < 
0.01) and 22% higher in RD-D than in RD (p < 0.05). 
After calcium electroporation (15 min and 1 
hour after), we observed a significantly higher calcium 
concentration in RD and RD-D cells (p < 0.5; Figure 2B). 
There was observed even 4-fold increased calcium level. 
In the normal C2C12 and C2C12-D cells, intracellular 
calcium concentration also increased after calcium 
electroporation, but less than in the RD and RD-D 
cells, and not significantly for all tested parameters 
compared with untreated controls (see Figure 2B). In the 
differentiated C2C12-D cells only the highest calcium 
Figure 1: The viability assay of normal and malignant cells in respectively undifferentiated and differentiated state 
after electroporation with/without calcium ions. (A) Undifferentiated normal mouse myoblast (C2C12) and malignant human 
rhabdomyosarcoma (RD) treated in suspension; (B) differentiated C2C12-D and RD-D cells treated in suspension; (C) differentiated, 
adherent normal mouse myoblast (C2C12) and malignant human rhabdomyosarcoma (RD); (D) differentiated, adherent C2C12-D and 
RD-D after treatment with calcium ions (0.5 mM and 5 mM) and electroporation (600, 800, and 1000 V/cm, respectively). Viability was 
determined using MTS assay 1 day after treatment. Results are presented as the percentage of control cells (non-electroporated cells 
without calcium ions addition). Mean ± SD, n ≤ 6; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, NS-not significant.
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concentration (1 mM) with electroporation caused 
significantly higher intracellular calcium concentration 
compared with untreated control (p < 0.05). Treatment 
with calcium alone did not significantly change the 
intracellular calcium level in any of the cell lines.
The difference in intracellular calcium after 
calcium electroporation in normal and malignant cells 
could indicate that there, amongst other, is a difference 
in how the cells remove the high calcium concentrations 
to re-establish the calcium homeostasis. We therefore 
investigated some of the calcium pumps and channels in 
the cells. 
Expression of PMCA proteins 
Plasma membrane calcium ATPase (PMCA) is the 
main pump responsible for removal of calcium ions out of 
the cell and thereby maintain proper intracellular calcium 
concentration [14]. We have investigated the expression 
of three of four isoforms of PMCA protein (PMCA1, 
PMCA3 and PMCA4) as well as the expression of all 
PMCA isoforms together (PMCAs) in normal (C2C12, 
C2C12-D) and malignant (RD, RD-D) cells. PMCA1 
and PMCA4 are ubiquitously expressed and described 
as “housekeeping” isoforms [15] while PMCA 3 protein 
is predominantly expressed in brain and skeletal muscle 
[16] and is more efficient in extruding calcium from 
the cells [17]. The PMCA 2 was omitted since it mostly 
expressed in the nervous system and mammary gland 
[18]. The total PMCA1-4 protein expression (Figure 
3A) was significantly higher in untreated normal cells 
than in malignant cells: twice as high in C2C12 than RD 
(p < 0.05), and 48% higher in C2C12-D than RD-D (p < 
0.01). Interestingly, the differentiation process increased 
PMCA1-4 expression by 44% for C2C12-D (p < 0.0001) 
and even doubled for RD-D (p < 0.0001). When estimating 
the PMCA isoforms individually, the normal cells 
presented higher expression of all the examined isoforms 
(PMCA1, PMCA3, PMCA4) compared to malignant 
cells, however not significantly for PMCA1 (Figure 3B). 
PMCA3 expression was almost twice as high in C2C12 
and C2C12-D compared with RD and RD-D (180–185%, 
p < 0.0001). The expression of PMCA4 (Figure 3D) was 
3.6-fold higher in C2C12 compared with RD (p < 0.0001) 
and 40% higher in C2C12-D than RD-D (p < 0.0001). 
Expression of NCX and RyR proteins 
The protein expression of two calcium channels, 
the sodium-calcium exchanger (NCX1) and the ryanodine 
receptor (RyR1) were also analyzed. NCX is a sodium-
calcium exchanger located in the plasma membrane that 
extrude Ca2+. In this study, NCX1 proteins were observed 
in the cytoplasm excluding nucleus. In the expression 
of NCX1, no significant difference was seen between 
untreated C2C12 and RD, but a higher expression in 
C2C12-D than RD-D, p < 0.05 (Figure 4A–4D). After 
calcium electroporation, NCX1 expression increased 
in normal C2C12 (p < 0.01) and C2C12-D (p < 0.001) 
cells. NCX1 expression also increased after treatment 
with electroporation alone in C2C12-D cells (p < 0.01) 
(Supplementary Figure 1B). Interestingly, unlike in the 
normal cells, the NCX1 protein expression significantly 
decreased in RD and RD-D cells after calcium 
electroporation (p < 0.001, p < 0.001) (Figure 4C and 
4D)as well as after electroporation alone (p < 0.01, p < 
0.001) (Supplementary Figure 1C and 1D). The lowered 
NCX1 expression and thereby lowered contribution in 
Figure 2: The intracellular calcium level after electroporation with Ca2+ of normal and malignant cell lines. The 
assessment of intracellular calcium levels in (A) untreated undifferentiated normal mouse myoblast – C2C12; differentiated normal mouse 
myoblast – C2C12-D; undifferentiated human rhabdomyosarcoma – RD; differentiated human rhabdomyosarcoma – RD-D and (B) after 
treatment with calcium (0.5 mM and 1 mM) with or without electroporation (EP; 1000 V/cm) measured 15 min and 1 h after treatment. 
Results are shown where control is normalized to 1 for each cell line. Mean ± SD, n ≤ 5. Results statistically significant compared to control 
cells, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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calcium removal in RD and RD-D cells after calcium 
electroporation may explain part of the problem of proper 
calcium homeostasis maintaining after treatment, which 
leads to cell death. 
Ryanodine receptor is responsible for calcium-
induced calcium release from calcium stores in the 
sarcoplasmic reticulum (SR). In the normal C2C12 cells, 
RyR1 expression was at the same level in untreated control 
as in cells treated with calcium alone, electroporation alone, 
and calcium electroporation (Figure 4E and Supplementary 
Figure 1E). However, in the differentiated C2C12-D 
cells, where the expression of RyR1 in untreated cells 
was higher than in C2C12 cells (p < 0.01), a decreased 
RyR1 expression was seen after CaEP (p < 0.05) (Figure 
4F and Supplementary Figure 1F). Untreated malignant 
(RD and RD-D, Figure 4G–4H) cells showed lower RyR1 
expression than normal cells (C2C12 and C2C12-D, p < 
0.05). There was no significant difference between RyR1 
signal in RD and RD-D as between C2C12 and C2C12-D 
cells; however, there was still a lower RyR1 expression after 
Figure 3: Plasma membrane calcium ATPase (PMCA) protein expression in normal muscle (C2C12) and malignant 
rhabdomyosarcoma (RD) cells. (A) Total PMCA, (B) PMCA isoform 1, (C) PMCA isoform 3, (D) and PMCA isoform 4 protein 
expression in undifferentiated normal mouse myoblast – C2C12; differentiated normal mouse myoblast – C2C12-D; undifferentiated 
human rhabdomyosarcoma – RD; differentiated human rhabdomyosarcoma – RD-D measured by western blotting. Representative blot 
with each sample loaded twice is shown below the graph. The protein level measured is relative to the 120 kDa maker (marked with an 
arrow). Mean ± SD, n = 3 each investigated in duplicates. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, NS – not significant.
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CaEP treatment in the RD and RD-D cells (p < 0.05). Unlike 
NCX1 expression, mostly intranuclear expression of RyR1 
was observed after treatment with electroporation and CaEP 
(Supplementary Figure 1G and 1H; Figure 4G and 4H).
Cytoskeleton structure after calcium 
electroporation
We also investigated cell morphology after 
treatment. First, F-actin and zyxin staining were performed 
to examine cytoskeleton before and after calcium 
electroporation (Figure 5 and Supplementary Figure 2). 
Differences in cytoskeleton structure between 
normal and malignant cells was seen. F-actin filaments in 
C2C12 and C2C12-D cells were well-organized in higher-
order structure, forming a stable net. The zyxin protein 
were co-localized with actin fibers on the membrane edges 
(Figure 5A–5B). It is evident that calcium electroporation 
stimulated zyxin expression in focal adhesion as well as 
actin stress fibers tension in normal cells, which is also 
seen in the graph where zyxin signal intensity increased 
after calcium electroporation (p < 0.05). RD and RD-D 
cells exhibited inferior organized F-actin fibers assembly 
with looser meshwork than presented in normal cells 
(Figure 5C–5D). The images also show that malignant 
cells (untreated and after incubation with 0.5 mM calcium) 
were rich in focal adhesion and lamellipodium which is 
responsible for cancer cells migration (Figure 5C and 5D; 
Supplementary Figure 2C and 2D). Both actin and zyxin 
were expressed strongly in the membrane protrusions. 
Electroporation with and without calcium disassembled 
actin cytoskeleton and inhibited zyxin expression. As seen 
in the graph, the intensity of the zyxin signal decreased 
(p < 0.05) after treatment with calcium electroporation, 
opposite the normal cells. RD and RD-D cells were small 
Figure 4: Immunofluorescent visualization of calcium/sodium exchanger (NCX1) and ryanodine receptor (Ryr1) in 
normal (C2C12, C2C12-D) and malignant (RD, RD-D) cells after exposition to CaEP protocol (electric field intensity: 
1000 V/cm and 0.5 mM Ca2+). The left panel: CLSM images present changes in NCX1 (red) intracellular localization and signal 
intensity between untreated and CaEP cell lines: C2C12 (A), C2C12-D (B), RD (C), RD-D (D). The graph shows signal intensity for 
untreated cell lines (above) and 3 therapy conditions (below): Ca2+ incubation, EP only and CaEP normalized to untreated cells. The right 
panel: confocal images present changes in RyR1 (green) signal intensity between untreated and CaEP cell lines: C2C12 (E), C2C12-D 
(F), RD (G), RD-D (H). Both NCX1 and RyR1 protein colocalized with F-actin and cellular nucleus. The graphs NCX1 (left) and RyR1 
(right) show a signal intensity for untreated cell lines (above) and 3 therapy conditions (below): Ca2+ incubation (0.5 mM), EP only (1000 
V/cm) and CaEP (0.5 mM; 1000 V/cm) normalized to untreated cells. Fluorescent signal was detected 24 h after CaEP application; 20 µm; 
n = 3–5. The signal intensity was analyzed by ImageJ software.
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and shrunk (Figure 5C–5D and Supplementary Figure 2C 
and 2D). 
Ultrastructure analysis by TEM method
Ultrastructure of normal and malignant cells was 
subjected to precise assessment by transmission electron 
microscope (TEM). Untreated normal C2C12 cells 
revealed the model composition of muscle cell structure 
with large nucleus with visible heterochromatin and active 
nucleolus, well-developed smooth endoplasmic reticulum 
(sER), and numerous mitochondria and lysosomes (Figure 
6A). CaEP did not affect the cell structure but the sER 
was replaced by rough endoplasmic reticulum (rER) and 
the number of free ribosomes increased drastically (Figure 
6B). Differentiated normal cells (C2C12-D) exhibited 
increased amount of rough endoplasmic reticulum, 
free ribosomes, and Golgi apparatus (Figure 6C). The 
nucleus was abounding in heterochromatin which might 
be categorized as facultative heterochromatin containing 
genes that are silent upon differentiation process [19]. 
Untreated malignant cells (RD, RD-D) were rich in 
mitochondria and ribosomes, which is a distinguishing 
mark of cancer cells and promotes their survivability 
(Figure 6E and 6G) [20]. After calcium electroporation of 
C2C12-D cells, an increased variety of secretory vesicles 
such as vacuoles, lysosomes, and residual bodies was 
seen (Figure 6D). These vesicles were also observed in 
malignant differentiated cells (RD-D) after CaEP as well as 
folded nucleus. Additionally, large, swollen mitochondria 
appeared with abnormal crista and distended rER (Figure 
6H). In RD cells, a significant apoptotic reaction was 
observed after calcium electroporation (Figure 6F) where 
the cell membrane integrity was strongly disrupted. 
Moreover, plenty of vacuoles and folded nuclei were also 
observed in these cells and particular cell organelles were 
difficult to identify. It all indicated the cell death processes 
confirmed by MTS assay (Figure 1). 
Figure 5: CLSM visualization of the rearrangement of zyxin and F-actin structure in normal (C2C12, C2C12) and 
malignant (RD, RD-D) cells. Middle panel presents immunofluorescence evaluation of zyxin (green) and actin (red) fibers expression 
for undifferentiated cell lines: C2C12 (A), RD (C) and differentiated cell lines: C2C12-D (B), RD-D (D) 24 h after calcium electroporation 
application. The white short arrows indicate focal adhesions, white long arrows indicate actin stress fibers; 20 µm; n = 3–5. The graphs 
Zyxin (left) and F-actin (right) show zyxin signal intensity and actin signal intensity for untreated cell lines (above) and 3 therapy conditions 
(below): Ca2+ incubation (0.5 mM), EP only (1000 V/cm) and CaEP (0.5 mM; 1000 V/cm) normalized to untreated cells. The signal 
intensity was analysed by ImageJ software.
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Figure 6: TEM figures presenting changes of the ultrastructure in normal (C2C12, C2C12-D) and malignant (RD, 
RD-D) rat muscle cells. The representative images present structure of intracellular organelles of untreated cells: C2C12 (A), C2C12-D 
(C), RD (E), RD-D (G) and 24 h after CaEP (1000 V/cm, 8 pulses, 100 µs): C2C12 (B), C2C12-D (D), RD (F), RD-D (H). Figure shows 
the results of one representative out of three independent experiments. N-nucleus; M-mitochondrion; G-Golgi apparatus; V-vacuoles; 
sER-smooth endoplasmic reticulum; rER-rough endoplasmic reticulum; R-free ribosomes; L-lysosomes; RB-residual bodies; dotted arrow 
indicates cell membrane disruption. 
Oncotarget11612www.impactjournals.com/oncotarget
Influence of calcium electroporation in vivo
Due to the promising in vitro results of calcium 
electroporation, the effect of the treatment was also tested 
in vivo. RD tumors, grown subcutaneously on NMRI-
Foxn1nu mice, were treated with calcium injection and 
electroporation using 1000 V/cm. Controls were treated 
with CaCl2
 injection alone, electroporation alone, and 
untreated (Figure 7). The largest difference in tumor 
volume between the untreated and CaEP treated was 
observed 10 days after treatment (45% decrease of 
tumor volume); however, tumors treated with calcium 
electroporation was not significantly different in volume 
from any of the control groups. The decrease of tumor 
volume after calcium alone and electroporation alone was 
unnoticeable. 
DISCUSSION
In this study, we have investigated the effect of 
calcium electroporation on normal and malignant muscle 
cells in vitro and in vivo. This study has confirmed 
our previous work about cytotoxic effect of calcium 
electroporation on malignant muscle cells, which 
increased with increasing calcium concentration and/
or applied voltage, as well as less effect was shown in 
normal muscle cells [8]. Moreover, this study is the first 
report about difference in response to CaEP between non-
differentiated and differentiated cells. Normal muscle 
cells, both undifferentiated and differentiated, preserved 
significantly higher cell viability than undifferentiated 
and differentiated malignant cells, respectively. 
Interestingly, there seems to be a slightly higher viability 
of differentiated cells than undifferentiated cells after 
treatment (significant only for parameters: 800V/cm 
with 5 mM Ca2+; p < 0.01) which indicate that both 
differentiated and undifferentiated cells should be tested 
for further experiments. The attached cells might also be 
less sensitive for CaEP than suspended cells, but it was not 
statistically significant. 
We showed an increased intracellular calcium 
concentration in all cells after calcium electroporation. 
A drastic increase of calcium level has a profound 
impact on cellular components such as cytoskeleton, 
cell membrane, opening of mitochondrion permeability 
transition pores (PTP), and elevating concentration of 
reactive oxygen species (ROS) [9]. Interestingly, we only 
confirmed significantly higher calcium content in RD 
and RD-D cells after CaEP using 0.5 mM calcium, not 
in C2C12 and C2C12-D cells. We hypothesized that this 
could have a background in the cell membrane structure 
and/or in quantity, type, and activity of ion channels and 
pumps [18,21,22]. Considering the physiological function 
of normal muscle cells (contraction and relaxation), they 
have a very efficient mechanism to maintain calcium 
homeostasis [23]. The results of this study indicate that 
plasma membrane calcium ATPase is higher expressed 
in normal muscle cells than malignant cells. Numerous 
Figure 7: Electroporation with calcium ions of rhabdomyosarcoma tumor in vivo. Human rhabdomyosarcoma tumors on 
nude mice were treated with calcium, calcium electroporation, electroporation alone, untreated. Mice were randomized and treated when 
tumors reached a volume of 85 mm3. Tumor volume was measured 2 times per week. Mean ± SD, n = 10 before treatment, n ≥ 6 is shown 
in the graph. 
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studies have shown, that up- or down-regulation of 
PMCA expression is depended on cancer cells types 
[24–26]. Our results describe a correlation between 
viability after treatment, intracellular calcium content, 
and PMCA expression, what confirms different response 
to calcium electroporation in normal and malignant cells, 
as previously shown in other cell types [10]. The higher 
expression of PMCA in normal cells indicates fast and 
efficient removal of calcium ions from the cytosol, which 
could increase viability. Lower expression of PMCA in 
malignant cells has also previously been shown [27, 28]. 
However, further experiments are needed to show the 
PMCA expression and activity after CaEP. 
We also proved that the expression of the sodium-
calcium exchanger (NCX1) is lower in malignant RD/
RD-D cells than normal C2C12/C2C12-D cells after 
calcium electroporation (p < 0.01). This is likely also 
leading to increased cytosolic Ca2+ and thereby lower 
cell viability in the malignant cells. Previous research 
suggested calcium removing as the main function of NCX 
in stimulated muscle cells [29]. In addition, NCX supports 
malignant cell proliferation and migration [30, 31], thus 
the reducing effect of CaEP on NCX expression may 
contribute to unveiling a new approach to fibrosarcoma 
treatment. 
Interestingly, NCX exchange Ca2+ for Na+, and 
the direction of the flux depends on the electrochemical 
gradient of both ions [32]. Thus, a thorough analysis of 
the impact of calcium electroporation on the NCX flux 
and thereby the Na+ and Ca2+ homeostasis is highly 
recommended. 
Muscle cells also maintain calcium homeostasis by 
storing calcium ions in sarcoplasmic calcium storages. 
The expression of ryanodine receptor (RyR), which play 
a crucial role in intracellular Ca2+ release from SR was 
therefore investigated. We showed a decrease of RyR1 
expression in normal differentiated cells C2C12-D (p < 
0.01) after calcium electroporation but not in RD-D cells. 
A reduction of RyR1 expression has previously been 
shown to induce cell death [33, 34], but this is not the case 
in this study, maybe due to the increased expression of 
PMCA and NCX in the normal cells. To further understand 
the impact of CaEP on calcium homeostasis, we suggest 
investigation of RyR activity, expression and activity of 
SERCA, and SR storage capacity should be performed. 
It has previously been shown that calcium 
electroporation causes acute and severe ATP depletion 
[7, 11–13]. This study does not encompass ATP 
examination however we previously showed that ATP 
uniformly and severely depleted across cell lines as a 
result of calcium electroporation but normal cells seem 
more resilient to this depletion than malignant cells. In this 
study, we found clear differences in survival after calcium 
electroporation in vitro between normal and malignant cell 
lines which is the important outcome. 
In this study, we have also investigated CaEP 
impact on cytoskeleton, particularly on zyxin and actin 
expression. Spatial structure of actin cytoskeleton is crucial 
for numerous processes such as cell migration, membrane 
extension, and extracellular signal transduction [35]. 
Zyxin is the main protein regulating actin cytoskeleton 
and stimulating spatially restricted actin polymerization 
[36, 37], which is strongly expressed in fast-growing ends 
of actin filaments e.g. lamellipodia [38]. It exports signal 
between nucleus and cell adhesion sites and creates cell-
cell focal adherent junctions [39]. According to previous 
studies, the membrane components spatial rearrangement, 
caused by electroporation, may affect the focal adhesion 
junctions and disturb zyxin expression leading to F-actin 
bundles unbinding [40, 41]. Our study is the very first to 
demonstrate that the impact of CaEP on zyxin distribution. 
In malignant RD/RD-D cells, this lead to loss of cell-cell 
contact and adherence. Interestingly, normal C2C12/
C2C12-D cells exhibit high zyxin expression and fast 
recovery processes induced at zyxin accumulation spots 
[42]. The higher viability rate of adherent cells is likely 
due to robust cytoskeleton. In contrast to suspended cells, 
they create well-organized cytoskeleton structure with cell-
cell junction, providing efficient cooperation and stable 
filaments assembly. In this unique study, we differentiated 
cells to investigate the importance of cell-cell contacts and 
development stage in calcium homeostasis after calcium 
electroporation treatment, which to our knowledge have 
not previously been shown. Our results show that there 
is a clear difference in the cytoskeleton structure after 
differentiation of normal and malignant cells, which might 
affect the cell response to calcium electroporation. 
We also investigated changes caused by calcium 
electroporation using transmission electron microscope 
(TEM). The most apparent differences caused by CaEP 
were visible in the malignant RD cells, mainly in damaged 
cell membrane and vacuolisation of cell compartments, 
which suggests late apoptosis. The enlarged, swollen 
mitochondria with disarrangement of cristae in RD-D 
cells appearing after calcium electroporation may indicate 
abnormal energy metabolism and ATP depletion leading 
to cell death [43,44], what correlates with the MTS results 
and previous studies which showed that ATP levels were 
acutely and severely depleted after electroporation alone 
as well as after calcium electroporation [7, 10]. Indeed, 
the mitochondrial function, including ATP production 
and involvement in the maintenance of intracellular 
calcium homeostasis, has previously been shown to be 
altered in cancer cells [45, 46]. This might also influence 
the effect of calcium electroporation. In contrast, CaEP 
strengthens metabolic activity of normal muscle cells 
by a number of free ribosomes that synthesize proteins 
essential for intracellular activity [47]. We might presume 
that calcium electroporation increase ribosome activity 
and protein expression in response to the fast upgrade of 
cell structures. Interestingly, after calcium electroporation, 
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normal C2C12-D cells exhibit a variety of secretory 
vesicles, which may indicate cell death pathway activation 
[48, 49]. However, high survival ratio was confirmed by 
MTS assay. Thus, the cellular recycling system might 
play a protective role by removing damaged organelles 
or cytotoxic substances, such as excessive calcium ions. 
This mechanism combined with a large number of active 
ribosomes might neutralize the harmful impact of the 
therapy. Autophagosomes deliver cytoplasmic components 
(organelles, molecules) to lysosomes, where digestion 
processes occur. Under unfavorable conditions, autophagy 
is activated and promotes cell survivability [50]. Further 
analyses towards vesicles origin are required. 
The promising effect of calcium electroporation in 
vitro was not confirmed in vivo when treating RD tumors 
on nude mice. Although, a slight decrease of the tumor 
volume was seen after CaEP compared with untreated 
control tumors, the differences were not statistically 
significant. The cells used was a human cell line which 
in in vivo studies cannot be injected in immunocompetent 
mice. The immune-incompetent mice used in this study 
may explain the weak tumor response. A recent study 
showed that calcium electroporation plays a crucial role 
in immune system stimulation [51–53]. This could explain 
the low effect of calcium electroporation in vivo. Another 
in vivo study proved significant tumor necrosis in 2 out 
of 4 tumor types treated with CaEP, which also confirms 
our results. Interestingly, in the same study, lower necrotic 
fraction was observed in normal muscle tissue directly 
treated with calcium electroporation compared with tumor 
tissue [10], which also confirms our in vitro data. 
Electrochemotherapy has been successfully used 
as local treatment of a variety of cancers for a quarter-
century. Yet, electrochemotherapy in rhabdomyosarcoma 
treatment has not been reported. Our innovative study 
suggests a possible novel treatment option, calcium 
electroporation, for sarcoma. This study clearly highlights 
the difference between calcium homeostasis in normal and 
malignant muscle cells, which is fundamental knowledge 
for the possible usage of this novel treatment. We have 
indicated that normal muscle cells more effectively re-
establish calcium homeostasis, which allows them to 
preserve higher viability than malignant cells after calcium 
electroporation. Further research focused on CaEP impact 
on calcium maintaining system in muscle cancer as well 
as other muscle disorders are highly recommended. This 
novel anticancer therapy seems to be very promising for 
targeted muscle cancer treatment in near future since the 
equipment, agent, and procedure are easily accessible, 
and the low-cost of this therapy may raise standards of 
treatment in many countries.
MATERIALS AND METHODS
Cell cultivation
The in vitro studies utilized two cell lines: 
C2C12 - mouse myoblast cell line and RD - human 
rhabdomyosarcoma cell line, respectively undifferentiated 
and differentiated [54,55]. The undifferentiated cell lines 
were grown in DMEM culture medium (Gibco) with 10% 
fetal calf serum, penicillin, streptomycin, and glucose (RD 
– 4.5 g/L, C2C12 – 1 g/L) at 37° C and 5% CO2. Both cell 
lines were tested negative for mycoplasma (MycoAlert, 
Lonza), and the RD cell line was authenticated by short 
tandem repeat profiling (LGC Standards) in April 2016 
showing a perfect match.
Differentiation was initiated at 70–90% cell 
confluence. Standard culture medium for C2C12 was 
changed for DMEM with 2% horse serum and 4.5 g/L 
glucose. For RD cells, standard culture medium was added 
12-O-tetradecanoyl-phorbol-13-acetate (TPA, 100 nM in 
EtOH; Sigma Aldrich). Culture medium was changed 
daily. Cells underwent differentiation over 5 days before 
experiments. 
Electroporation of cells in suspension
Cells (270 µl of 6.1 × 106 cells/ml) suspended in 
HEPES buffer (10 mM HEPES (Lonza), 250 mM sucrose, 
and 1 mM MgCl2 in sterile water) and 30 µl of CaCl2 (0.5, 
1, or 5 mM in final concentration) or HEPES for controls 
incubated 5 min at 37° C in a 4 mm cuvette (Molecular 
BioProducts, Inc.). Cells were exposed to 8 pulses of 99 
µs, 1 Hz, and 600, 800, or 1000 V/cm using a square wave 
electroporator (BTX T820, Genetronics, USA). After 20 
min incubation at 37° C, cells were suspended in culture 
medium and seeded in 96-well plates (3.1 × 104 cells 
per 100 µl) and incubated for 24 h at 37° C. MTS assay 
was performed using Multiscan-Ascent ELISA reader 
(ThermoLabsystems).
Electroporation of attached cells
In glass bottom dishes (HBSt-3512, WillCo Wells), 
300 µl of cells (1.66 × 105) seeded in culture medium 
and incubated overnight (undifferentiated cells) or 5 days 
(differentiated cells). Cells in HEPES buffer containing 
0.5 or 5 mM CaCl2 were electroporated using a square 
wave electroporator (Cliniporator, IGEA) and a custom-
made contact copper electrode device with 8 mm between 
the electrodes (same parameters as described above). 
After electroporation, plates incubated for 20 min at 
37° C before HEPES buffer was changed to 1.5 ml culture 
medium. Cells incubated at 37° C for 24 h. Before MTS 
assay, culture medium was substituted by 100 µl medium 
and 20 µl MTS and incubated for 1.5 h. Cell viability was 
measured as described above. 
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Calcium level measurement
Intracellular calcium level was measured for the 
two cell lines, undifferentiated and differentiated. Cells 
were divided into seven groups: Calcium electroporation 
(0.5 and 1 mM) collected 15 and 60 min after treatment, 
calcium alone (0.5 and 1 mM) collected after 60 min, and 
untreated. Cells were electroporated in suspension using 
1000 V/cm. After treatment, cells were suspended in 50 µl 
lysis buffer for 30 min, centrifuged, and the supernatant 
was collected. Total intracellular calcium concentration 
was measured using Calcium Colorimetric Assay Kit (Bio 
Vision) in 96-well plates. A standard curve was generated 
using serial dilutions of CaCO3 (0–2 mg/dl). Absorbance 
was measured using Multiscan-Ascent ELISA reader 
(ThermoLabsystems) at 575 nm. The obtained results 
were expressed as Ca2+ level in mM where 1 mg/dl CaCO3 
corresponds with 0.1 mM Ca2+.
Western blot
Undifferentiated and differentiated C2C12 
and RD cell lines were examined for PMCA protein 
expression. Cell suspensions were incubated in lysis 
buffer (137 mmol/L, 20 mmol/L Tris, 1 % nonidet P 40, 
10% glycerol, 1 mmol/L PMSF Sigma P7626, 10 µg/ml 
Aprotinin Sigma, 0.5 mmol/L natrium metavanadate Sigma 
590088, 1 µ/ml leupeptin Sigma L2882; pH = 8.0) on ice 
for 30 min with agitation. Supernatant collected after 
centrifugation (8,000 g × 3 min). Protein concentration 
were measured by BCA Protein Assay (Pierce) and 20 µg 
of total protein extract was mixed with Sample Load 
Buffer (Invitrogen) and reducing agent (Invitrogen), heated 
for 5 min at 90° C, and separated on NuPAGE 3–8% Tris-
Acetate Gel together with a pre-strained protein marker 
and a Magic marker (Novex; 150 V for 1 h). The separated 
protein was transferred to a PVDF membrane (Invitrogen) 
using wet blotting (1.5 h; 90 mA). The membrane was 
incubated overnight with diluent A and B (Invitrogen) in 
2:3 ratio to block for unspecific binding prior to incubation 
(1 h) with the primary antibody. Antibodies were diluted 
in diluent A and B (ratio 2:1). Four primary antibodies 
(1:1000) were used: mouse-anti-PMCA antibody 5F10 
(Thermo Fisher Scientific), mouse anti-PMCA-4 antibody 
JA9 (Thermo Fisher Scientific), rabbit monoclonal anti-
PMCA-1 antibody EPR12029 (Abcam), and rabbit 
polyclonal anti-PMCA-3 antibody ab84521 (Abcam). 
Then, the membrane was washed in 1X Wash buffer for 
2 × 10 min followed by incubation with secondary HPR 
conjugated antibody (1:10.000) diluted in a 2:1 mixture of 
diluent A and B. Unbound antibody was removed with a 
second wash procedure (2 × 10 min). The membrane was 
incubated with a Chemiluminescent Substrate Reagent 
Kit (Invitrogen) for 5 min with minimal light exposure. 
Signal was elicited using LAS-4000 Chemiluminescence 
and Fluorescence Imaging System (Fujitsu Life Science). 
Band intensity was estimated and compared to the 120 kDa 
band of the Magic marker (Invitrogen).
Confocal laser microscopy study (CLSM)
Confocal microscope was used to evaluate 
cytoskeleton structure and calcium ion channels 
expression in adherent cells after calcium electroporation 
(0.5 mM, 1000 V/cm). Cells (103/100 μl) were incubated 
on cover glasses in Petri dishes overnight. The treatment 
(calcium electroporation, calcium alone, electroporation 
without calcium, untreated) using Petri Pulser Electrode 
with 2 mm gaps between electrodes (BTX model 45–
0130) was performed. Then after 24 h cells were fixed 
in 4% formalin, permeabilized with 0.5% Triton X-100 
in PBS for 5 min, raised in PBS 3 × 5 min, blocked with 
1% Bovine Serum Albumin (BSA) in PBS for 1 h. These 
antibodies were used: 1) to show cytoskeleton structure – 
primary antibody monoclonal mouse anti-zyxin (overnight 
incubation at 4° C; 1:500; Abcam) and secondary antibody 
Fluorescein (FITC)-conjugated AffiniPure Fragment 
Donkey Anti-Mouse IgG (for 60 min; at room temperature; 
1:100; Jackson ImmunoResearch) mixed with Alexa 
546-conjugated phalloidin (at a concentration of 2 μg/ml; 
Life Technologies); 2) to show ryanodine receptors 
expression – primary antibody monoclonal rabbit anti-
RyR1 (overnight at 4° C; 1:100, Cell Signaling) and 
secondary antibody Cy3-conjugated AffiniPure Donkey 
Anti-Rabbit IgG (for 60 min at the room temperature; 
1;100; Jackson ImmunoResearch) mixed with Alexa 
488-conjugated phalloidin (at a concentration of 2 μg/ml; 
Life Technologies); 3) to show sodium/calcium exchanger 
expression – primary antibody monoclonal mouse anti-
NCX1 (overnight at 4° C; 1:100, Abcam) and secondary 
antibody Fluorescein (FITC)-conjugated AffiniPure 
Fragment Donkey Anti-Mouse IgG (for 60 min; at the 
room temperature; 1:100; Jackson ImmunoResearch) 
mixed with Alexa 546-conjugated phalloidin (at a 
concentration of 2 μg/ml; Life Technologies). DNA 
staining with DAPI (4,6-diamidino-2-phenylindole; 
0.2 μg/ml) was performed. Cells were mounted in 
Fluorescence mounting medium (DAKO). For imaging, 
Olympus FluoView FV1000 confocal laser scanning 
microscope (Olympus) were used.
Transmission electron microscopy (TEM) study
Morphological structures of cells were assessed 
using transmission electron microscope Zeiss EM 900 
24 h after: calcium electroporation (0.5 mM, 1000 V/
cm); calcium alone (0.5 mM); electroporation alone 
(1000 V/cm); untreated cells. Cells were electroporated 
in suspension. Cells were fixed in 2.5% glutaraldehyde 
for 12 h, washed in 0.1 M phosphate buffer (pH 7.4) 3 
times, post-fixed in 1% osmium tetroxide for 30 min and 
dehydrated through a graded series of acetone. Samples 
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were embedded in Epon (EMbed 812 Kit, Electron 
Microscopy Sciences).
Calcium electroporation in vivo
Experiments were conducted in accordance with 
European Convention for the Protection of Vertebrate 
Animals used for Experimentation and with permission 
from the Danish Animal Experiments Inspectorate. RD 
cells (5 × 106 in 100 µl PBS) were injected subcutaneously 
in the flank of 8- to 12-week-old NMRI-Foxn1nu mice 
(Harlan and bred at Department of Oncology, Herlev 
Hospital, Denmark). Hypnorm-dormicum (VetaPharma 
and Roche) was used as anesthesia. Tumor size was 
measured using a Vernier Caliper and calculated 
according to the equation: ab2π/6 (a, largest diameter; 
b, largest diameter perpendicular to a). Mice were 
randomized in four groups when the tumors were above 
85 mm3: (1) calcium chloride (168 mmol/L) injection; 
(2) calcium chloride injection (168 mmol/L) followed 
by electroporation (8 pulses of 100 μs at 1000 V/cm, and 
1 Hz) using a 6 mm plate electrode and a square wave 
electroporator (Cliniporator, IGEA); (3) electroporation 
alone (parameters as above); (4) untreated. Injection 
volume of CaCl2 was equivalent to 50% of the tumor 
volume. Response of the treatment was followed by 
measuring tumor size twice a week.
Statistics
Statistical analyses were performed using SPSS 
software (version 19). Differences in viability in vitro, 
in intracellular calcium level in vitro, and in florescent 
signal intensity were assessed by 2-way analysis of 
variance (ANOVA) with post least-squares-means test 
with Bonferroni correction. In the event of violation of 
the assumption of data being normally distributed, data 
was log transformed. Differences in tumor volume after 
treatment in vivo were evaluated with linear mixed model.
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